Andrew J. Forman

Partner
Washington,  DC  U.S.A.
Phone202-862-2243

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Antitrust
  • Antitrust Litigation & Civil Investigations
  • M&A Clearance & Counseling
  • Grand Jury and Cartel Investigations, Amnesty, and Compliance
  • Litigation
 
Contact InfoTelephone: 202-862-2243
Fax: 202 862 2400
http://www.cadwalader.com/professionals/andrew-forman
 
University Washington University, St. Louis, B.A., with honors, 1995
 
Law SchoolGeorgetown University Law Center, J.D., cum laude, 2000
 
Admitted2000, Maryland; 2002, District of Columbia
 
LanguagesFrench
 
Biography

Andrew Forman's practice involves counseling clients in a wide range of antitrust matters, with a specific focus on mergers and acquisitions, joint ventures, and representing clients in connection with investigations by the U.S. Department of Justice and the Federal Trade Commission (FTC). Andy also has experience in private antitrust litigation, including antitrust class action litigation. He has represented clients in matters involving a variety of industries, including the pharmaceutical, medical device, airline, automobile, software, semiconductor, industrial and engineered products, and consumer products industries. Among the clients Andy has represented are Eli Lilly, Salix, Anheuser-Busch InBev, US Airways, Pfizer, Microsoft, and Goodyear.

Recognized as a leading antitrust lawyer, Andy has helped lead the Cadwalader teams that have won the last two Global Competition Review antitrust Matter of the Year awards, in 2015 for work with Eli Lilly & Company in connection with its acquisition of Novartis Animal Health and in 2014 for work in connection with the US Airways/American Airlines merger. He also was recommended in The Legal 500 (2012 -2013) for his work in merger clearances and was part of the team accepting Benchmark Litigation's award for 2013 U.S. Antitrust Group of the Year and for a national Impact Case of the Year awardfor the US Airways/American merger clearance.

Prior to joining Cadwalader, Andy worked for the FTC's Bureau of Competition (Mergers I), where he helped lead antitrust investigations in large mergers and acquisitions in the pharmaceutical, medical device, consumer products, industrial products, and aircraft components industries.

Andy received his J.D., cum laude, from Georgetown University and his undergraduate degree as an Honors Graduate from Washington University in St. Louis. Following law school, he served as a judicial law clerk for the D.C. Court of Appeals. He is admitted to the bar in the District of Columbia and Maryland.

Experience

Antitrust representations include:

•Salix Pharmaceuticals, Ltd. in its $15.6 billion acquisition by Valeant Pharmaceuticals International, Inc.
•Eli Lilly & Company in connection with its $5.4 billion acquisition of Novartis Animal Health.
•Acorda Therapeutics, Inc. in its pending acquisition of Civitas Therapeutics, Inc.
•Salix Pharmaceuticals in connection with its proposed transaction with Cosmo Technologies.
•US Airways in its $17 billion merger with American Airlines.
•Vertis Holdings, Inc., an advertising and direct mail company, in connection with its bankruptcy sale to rival Quad/Graphics, Inc.
•US Airways in its slot transaction with Delta Air Lines.
•Pfizer Inc. in its $68 billion acquisition of Wyeth Pharmaceuticals.
•Microsoft Corporation in numerous antitrust matters.
•Elan Corporation PLC in the $3.3 billion sale of its multiple sclerosis joint venture interest to Biogen Idec, Inc.
•Anheuser-Busch InBev in various antitrust matters.
•Goodyear Tire & Rubber Company in various antitrust matters.

NEWS

News Releases
Cadwalader Represents Towers Watson in its Acquisition of Acclaris, a Healthcare Technology Provider May 11, 2015

Recent Press
New Deals - Lawyers on Major Transactions Jan 29, 2009

Recognition
Cadwalader's Antitrust Group Wins 2015 Global Competition Review Matter of the Year Award Apr 15, 2015

RESOURCES

Clients & Friends Memos
Recent Court and Agency Actions Suggest Increased Antitrust Risk Over Disgorgement, Particularly in the Pharmaceutical Industry May 05, 2015

Articles
6 Steps for Quick FTC Antitrust Clearance of Pharma Mergers May 01, 2015

Events
So The Agency Wants to Talk: Advice and Issues in Pre-Complaint Depositions Mar 16, 2015

Clerkship
Senior Judges' Chambers
District of Columbia Court of Appeals

 
ISLN916984357
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

Recent Court and Agency Actions Suggest Increased Antitrust Risk Over Disgorgement, Particularly in the Pharmaceutical Industry
Andrew J. Forman,Daniel J. Howley,Charles F. (Rick) Rule,Eric Sega, May 13, 2015
Recent court and agency rulings highlight important takeaways involving disgorgement in antitrust proceedings. Companies, especially those in the pharmaceutical industry, increasingly should ensure they properly calibrate the potential for disgorgement in their antitrust risk calculus.

Takeaways from the Ninth Circuit’s Opinion Affirming the FTC’s Victory Against the St. Luke's/Saltzer Merger
Andrew J. Forman,Daniel J. Howley,Jonathan S. Kanter,Charles F. (Rick) Rule,Eric Sega, March 26, 2015
On February 10, 2015, the United States Court of Appeals for the Ninth Circuit affirmed a district court’s ruling that St. Luke’s Health System’s acquisition of the independent physician group Saltzer Medical Group violated the antitrust laws. This appellate victory is another in...
Profile Visibility
#772 in weekly profile views out of 59,584 lawyers in Washington, District of Columbia
#32,125 in weekly profile views out of 1,708,981 total lawyers Overall

Office Information

Andrew J. Forman

700 Sixth Street, N.W.
WashingtonDC 20001




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now